The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Apr 2021
Randomized Controlled Trial70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
The MINDACT trial showed excellent 5-year distant metastasis-free survival of 94·7% (95% CI 92·5-96·2) in patients with breast cancer of high clinical and low genomic risk who did not receive chemotherapy. We present long-term follow-up results together with an exploratory analysis by age. ⋯ European Commission Sixth Framework Programme.